106 studies found for:    Open Studies | "Adrenal Gland Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Adrenal Gland Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study
Conditions: Adrenal Mass;   Adrenal Disease;   Pheochromocytoma;   Cushing Syndrome
Interventions: Procedure: Posterior retroperitoneoscopic adrenalectomy;   Procedure: Transperitoneal laparoscopic adrenalectomy
2 Recruiting Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
Condition: Adrenal Disease
Interventions: Procedure: PRA;   Procedure: LA
3 Not yet recruiting Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: CORT125134
4 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
5 Recruiting Primary Aldosteronism in Western Norway
Condition: Hyperaldosteronism
Intervention:
6 Not yet recruiting Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Conditions: Functional Pancreatic Neuroendocrine Tumor;   Malignant Somatostatinoma;   Merkel Cell Carcinoma;   Metastatic Adrenal Gland Pheochromocytoma;   Metastatic Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2B;   Neuroendocrine Neoplasm;   Non-Functional Pancreatic Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adrenal Gland Pheochromocytoma;   Recurrent Merkel Cell Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor;   Stage III Adrenal Cortex Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IIIA Merkel Cell Carcinoma;   Stage IIIB Merkel Cell Carcinoma;   Stage IV Adrenal Cortex Carcinoma;   Stage IV Merkel Cell Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Thymic Carcinoid Tumor;   VIP-Producing Neuroendocrine Tumor;   Well Differentiated Adrenal Cortex Carcinoma;   Zollinger Ellison Syndrome
Interventions: Drug: Capecitabine;   Drug: Temozolomide;   Drug: Veliparib;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
7 Recruiting Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests
Condition: Adrenal Insufficiency
Intervention: Drug: Synachten
8 Recruiting Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia
Condition: General Glucocorticoid Resistance
Intervention: Genetic: blood collection for mutation characterization
9 Recruiting A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: ATR-101
10 Not yet recruiting Prenatal Dex Study
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Neuropsychological and cognitive assessment
11 Not yet recruiting The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
Condition: Cushing Syndrome
Intervention:
12 Recruiting SOM230 Ectopic ACTH-producing Tumors
Condition: Ectopic ACTH Syndrome
Intervention: Drug: Pasireotide
13 Recruiting Evaluation of Children With Endocrine and Metabolic-Related Conditions
Conditions: Adrenal Insufficiency;   Growth Disorder;   Endocrine Diseases;   Metabolic Disease;   Bone Diseases, Metabolic
Intervention:
14 Not yet recruiting Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism
Conditions: Primary Aldosteronism;   Adrenal Adenoma
Intervention: Device: Radiofrequency ablation
15 Recruiting Optimizing Diagnosis Of Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention:
16 Not yet recruiting Sleep Apnea Diagnosis Using a Novel Pace-maker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction (SAPAAD)
Conditions: Sleep Apnea;   Arrhythmias, Cardiac;   Cardiac Diastolic Function;   Hyperaldosteronism
Interventions: Other: pacemaker diagnostic algorithm;   Other: Attended cardiorespiratory sleep study
17 Not yet recruiting Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
Conditions: Adrenal Cortex Neoplasms;   Adrenal Cortex Diseases
Intervention:
18 Recruiting Extension Study for Patients Entered Into Study Infacort 003
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
19 Recruiting Treatment of Adrenal Insufficiency in Children
Condition: Adrenal Insufficiency
Intervention: Drug: Infacort®
20 Recruiting Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Conditions: Metastatic Carcinoma in the Adrenal Cortex;   Recurrent Adrenal Cortex Carcinoma;   Stage III Adrenal Cortex Carcinoma;   Stage IV Adrenal Cortex Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nivolumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years